Can AAV continue to deliver the promise of gene therapy?
The BioInsights Podcast
The BioInsights Podcast
Can AAV continue to deliver the promise of gene therapy?
Sep 13, 2023 Season 2 Episode 13
BioInsights

In this episode, Charlotte Barker, Editor, BioInsights, will be discussing the future of AAV-based gene therapy manufacturing with Elie Hanania, VP of Process Development Viral Vector Technologies at Avid Bioservices, and Ratish Krishnan, Senior Strategy Consultant at Merck Life Sciences.